The global Full-length Transcriptome Sequencing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Full-length Transcriptome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Full-length Transcriptome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Full-length Transcriptome Sequencing in Biomedical Field is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Full-length Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Eurofins Scientific, Azenta, LabCorp and BGI Genomics, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Full-length Transcriptome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Full-length Transcriptome Sequencing.
The Full-length Transcriptome Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Full-length Transcriptome Sequencing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Full-length Transcriptome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Segment by Type
Total RNA
Noncoding RNA
Segment by Application
Biomedical Field
Non-medical Field
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Full-length Transcriptome Sequencing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Full-length Transcriptome Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Total RNA
1.2.3 Noncoding RNA
1.3 Market by Application
1.3.1 Global Full-length Transcriptome Sequencing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biomedical Field
1.3.3 Non-medical Field
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Full-length Transcriptome Sequencing Market Perspective (2018-2029)
2.2 Full-length Transcriptome Sequencing Growth Trends by Region
2.2.1 Global Full-length Transcriptome Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Full-length Transcriptome Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Full-length Transcriptome Sequencing Forecasted Market Size by Region (2024-2029)
2.3 Full-length Transcriptome Sequencing Market Dynamics
2.3.1 Full-length Transcriptome Sequencing Industry Trends
2.3.2 Full-length Transcriptome Sequencing Market Drivers
2.3.3 Full-length Transcriptome Sequencing Market Challenges
2.3.4 Full-length Transcriptome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Full-length Transcriptome Sequencing Players by Revenue
3.1.1 Global Top Full-length Transcriptome Sequencing Players by Revenue (2018-2023)
3.1.2 Global Full-length Transcriptome Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Full-length Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Full-length Transcriptome Sequencing Revenue
3.4 Global Full-length Transcriptome Sequencing Market Concentration Ratio
3.4.1 Global Full-length Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Full-length Transcriptome Sequencing Revenue in 2022
3.5 Full-length Transcriptome Sequencing Key Players Head office and Area Served
3.6 Key Players Full-length Transcriptome Sequencing Product Solution and Service
3.7 Date of Enter into Full-length Transcriptome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Full-length Transcriptome Sequencing Breakdown Data by Type
4.1 Global Full-length Transcriptome Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Full-length Transcriptome Sequencing Forecasted Market Size by Type (2024-2029)
5 Full-length Transcriptome Sequencing Breakdown Data by Application
5.1 Global Full-length Transcriptome Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Full-length Transcriptome Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Full-length Transcriptome Sequencing Market Size (2018-2029)
6.2 North America Full-length Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Full-length Transcriptome Sequencing Market Size by Country (2018-2023)
6.4 North America Full-length Transcriptome Sequencing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Full-length Transcriptome Sequencing Market Size (2018-2029)
7.2 Europe Full-length Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Full-length Transcriptome Sequencing Market Size by Country (2018-2023)
7.4 Europe Full-length Transcriptome Sequencing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Full-length Transcriptome Sequencing Market Size (2018-2029)
8.2 Asia-Pacific Full-length Transcriptome Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Full-length Transcriptome Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Full-length Transcriptome Sequencing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Full-length Transcriptome Sequencing Market Size (2018-2029)
9.2 Latin America Full-length Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Full-length Transcriptome Sequencing Market Size by Country (2018-2023)
9.4 Latin America Full-length Transcriptome Sequencing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Full-length Transcriptome Sequencing Market Size (2018-2029)
10.2 Middle East & Africa Full-length Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Full-length Transcriptome Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Full-length Transcriptome Sequencing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Full-length Transcriptome Sequencing Introduction
11.1.4 Illumina Revenue in Full-length Transcriptome Sequencing Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Full-length Transcriptome Sequencing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Full-length Transcriptome Sequencing Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Full-length Transcriptome Sequencing Introduction
11.3.4 Bio-Rad Revenue in Full-length Transcriptome Sequencing Business (2018-2023)
11.3.5 Bio-Rad Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Full-length Transcriptome Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Full-length Transcriptome Sequencing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Full-length Transcriptome Sequencing Introduction
11.5.4 QIAGEN Revenue in Full-length Transcriptome Sequencing Business (2018-2023)
11.5.5 QIAGEN Recent Development
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Detail
11.6.2 Eurofins Scientific Business Overview
11.6.3 Eurofins Scientific Full-length Transcriptome Sequencing Introduction
11.6.4 Eurofins Scientific Revenue in Full-length Transcriptome Sequencing Business (2018-2023)
11.6.5 Eurofins Scientific Recent Development
11.7 Azenta
11.7.1 Azenta Company Detail
11.7.2 Azenta Business Overview
11.7.3 Azenta Full-length Transcriptome Sequencing Introduction
11.7.4 Azenta Revenue in Full-length Transcriptome Sequencing Business (2018-2023)
11.7.5 Azenta Recent Development
11.8 LabCorp
11.8.1 LabCorp Company Detail
11.8.2 LabCorp Business Overview
11.8.3 LabCorp Full-length Transcriptome Sequencing Introduction
11.8.4 LabCorp Revenue in Full-length Transcriptome Sequencing Business (2018-2023)
11.8.5 LabCorp Recent Development
11.9 BGI Genomics
11.9.1 BGI Genomics Company Detail
11.9.2 BGI Genomics Business Overview
11.9.3 BGI Genomics Full-length Transcriptome Sequencing Introduction
11.9.4 BGI Genomics Revenue in Full-length Transcriptome Sequencing Business (2018-2023)
11.9.5 BGI Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
听
听
*If Applicable.
